Breast Cancer Special Issue | CURE

October 26, 2016

For many patients with early-stage breast cancer, these drugs provide a significant boost to disease-free survival.

October 26, 2016

Laura Yeager talks about her journey with breast cancer, from the fearful thoughts to the free food at chemotherapy.

October 26, 2016

Biosimilars are changing the field — and the price — of cancer treatment, though some questions still remain.

October 25, 2016

Extending hormonal therapy to 10 years has been found to reduce recurrence in HR-positive breast cancer.

October 25, 2016

In some cases, genomic blood analysis may be effective enough to replace cancer biopsies.

October 25, 2016

Biosimilars are likely to rival name-brand treatments for breast and other cancers, and the competition could drive prices down.

October 23, 2016

Joining cancer registries can help patients and the larger oncology community.

October 22, 2016

Herceptin has improved survival for women with HER2-positive breast cancer. Now, scientists are exploring ways to mitigate the heart problems the drug can cause.

October 21, 2016

Excitement is growing over new strategies for treating or avoiding peripheral neuropathy in patients with cancer.

October 20, 2016

Once considered “immunologically silent,” breast cancer may actually respond to immunotherapy.

October 20, 2016